Skip to main content
Equibles
COCH logo

COCH · Envoy Medical, Inc.

Track COCH — free

Use COCH with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about COCH

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$0.80 +0.05 (+7.20%) At close · Aug 14
Going-concern doubt — flagged Aug 10, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These matters raise substantial doubt about the Company's ability to continue as a going concern and although management has developed plans intended to support ongoing operations, such plans do not alleviate the substantial doubt.”
View the 10-Q filed Aug 10, 2026
Market Cap
$61.76M
Shares
77.19M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.80 Open$0.75 Day$0.74–0.81 52W close$0.39–1.59 Avg vol 30d285K Short int976K · 1.3% float · 3.4d Short vol42% DataApr 2021–Aug 2026 Filing10-Q · Aug 10

Up next

FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 10, 2026

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Buy Momentum Very Strong Sentiment Bearish Fundamentals Weak Quant / Vol Very High
Market backdrop VIX 14.3 · calm Equity put/call 0.52
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +14%
above
Price vs 50-day avg +16%
above
RSI (14) 65
neutral
MACD trend Positive
52-week position 34%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Strong
1-month return +14%
trailing
6-month return +15%
trailing
YTD return +21%
this year
Relative strength +1%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow Distributing
-9% holders QoQ · +7 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
1.26% of float · ▲ +11.0% MoM · 3.4 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
59 holders — mid 3-yr range
Squeeze score 67
elevated · 0–100
Fundamentals
Weak
Revenue growth +7%
Y/Y
EPS growth +17%
Y/Y
Free cash flow $-18.4M
Balance sheet $5.9M
net debt
Quant / Vol
risk profile
Very High
Volatility 151%
annualized · 1-yr
Max drawdown −75%
past year
ATR 6.7%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Buy
0 · 4 · 3
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+14% Bullish
Price vs 50-day avg
+16% Bullish
RSI (14)
65 Neutral
MACD trend
Positive Bullish
52-week position
34% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow Distributing
-9% holders QoQ · +7 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
1.26% of float · ▲ +11.0% MoM · 3.4 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
59 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $0 Now $1 · 34% Range high $2
vs 200-day avg +14% vs 50-day avg +16%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
mean Consonant-Nucleus-Consonant (CNC) word recognition score 53.2% 12-month visits —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Medical Devices — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
COCH
Envoy Medical, Inc.
this stock
$61.76M +21.0% +7.1% — 1.3%
ABT
Abbott Laboratories
 $193.78B -11.2% +5.7% 31.2 1.3%
SYK
Stryker Corp
 $130.11B -3.5% +11.2% 35.2 2.2%
MDT
Medtronic plc
 $116.83B -5.0% +8.4% 24.5 1.4%
BSX
Boston Scientific Corp
 $75.11B -45.6% +12.5% 21.0 1.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
59
% held
29.8%
Net QoQ
+140.1K sh
Top holder
Nantahala Capital Managem…
Held Float
View
Held by Funds
Fund positions
9
View
Short & Settlement
Short Interest Rising
Shares short
976.3K
Days to cover
3.4d
Change
+96.5K sh
View
Short Volume
Short vol %
42%
As of
Aug 14, 2026
Short Total
View
Fails to Deliver
FTD shares
4
Value
$3
As of
Jul 6, 2026
View
Off-Exchange
Off-exchange %
60.6%
Week of
Jul 6, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$241.0K
Net income (FY)
$-23.8M
EPS diluted
$-1.23
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 10, 2026
This year
17
View

Performance

5D 20D 120D MTD YTD
COCH +19.2% +14.0% +14.9% +19.2% +21.0%
SPY +0.4% +4.5% +13.8% +3.9% +13.9%
vs SPY +18.8% +9.5% +1.2% +15.3% +7.2%
Key facts CIK 1840877 CUSIP 29415V109 13F (30d) 55 filings 55 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)